| Sign In to gain access to subscriptions and/or personal tools. |
Etiopathogenesis of Parkinson Disease: A New Beginning?Department of Neurology, Baylor College of Medicine, Houston, Texas
Department of Neurology, Baylor College of Medicine, Houston, Texas
Department of Neurology, Baylor College of Medicine, Houston, Texas, josephj{at}bcm.tmc.edu Parkinson disease (PD) probably represents a syndrome of different disorders and origins converging into a relatively uniform neurodegenerative process. Although clinical-pathological studies have suggested that the presymptomatic phase of PD may be relatively short, perhaps less than a decade, the authors postulate that the pathogenic mechanisms may begin much earlier, possibly even in the prenatal period. Thus, some patients with PD may be born with a fewer than normal number of dopaminergic (and nondopaminergic) neurons as a result of genetic or other abnormalities sustained during the prenatal or perinatal period; as a result of normal age-related neuronal attrition, they eventually reach the critical threshold (60% or more) of neuronal loss needed for onset of PD to become clinically manifest. The authors review the emerging evidence that genetic disruption of normal development, coupled with subsequent environmental factors (the so called multiple-hit hypothesis), plays an important role in the etiopathogenesis of PD.
Key Words: transcription factors • gene regulation • dopamine neuron development • environmental neurotoxins
This version was published on February
1, 2009 The Neuroscientist, Vol. 15, No. 1,
28-35 (2009) This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
Sign In to gain access to subscriptions and/or personal tools.
